These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. How do you measure "success" in a biotechnology company? Greetham EM Nat Biotechnol; 1998 May; 16 Suppl():59-60. PubMed ID: 9591275 [No Abstract] [Full Text] [Related]
30. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation. Reed SD; Califf RM; Schulman KA Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727 [TBL] [Abstract][Full Text] [Related]
31. Company stock prices before and after public announcements related to oncology drugs. Rothenstein JM; Tomlinson G; Tannock IF; Detsky AS J Natl Cancer Inst; 2011 Oct; 103(20):1507-12. PubMed ID: 21949081 [TBL] [Abstract][Full Text] [Related]
32. Can personalized drugs pay off? Stipp D Fortune; 2002 May; 145(10):168. PubMed ID: 12025349 [No Abstract] [Full Text] [Related]
33. Sense and antisense for investors. Jacobs T Nat Biotechnol; 2002 Jun; 20(6):543. PubMed ID: 12042846 [No Abstract] [Full Text] [Related]
34. The decreased number of new drug approvals (NDAs) has been a topic of considerable debate over the past decade. Preface. Enna SJ; Williams M Adv Pharmacol; 2009; 57():xi-ii. PubMed ID: 19945649 [No Abstract] [Full Text] [Related]
35. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors. Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098 [No Abstract] [Full Text] [Related]
36. Pharma consolidates its grip on post-antibody landscape. Sheridan C Nat Biotechnol; 2007 Apr; 25(4):365-6. PubMed ID: 17420728 [No Abstract] [Full Text] [Related]
38. Quantifying the magnitude and cost of collecting extraneous protocol data. Getz KA; Stergiopoulos S; Marlborough M; Whitehill J; Curran M; Kaitin KI Am J Ther; 2015; 22(2):117-24. PubMed ID: 23429165 [TBL] [Abstract][Full Text] [Related]
39. Can Merck stand alone? Warner M Fortune; 2001 Jul; 144(2):62. PubMed ID: 11471356 [No Abstract] [Full Text] [Related]
40. A new prescription for your portfolio. Clifford L; O'Keefe B; Stires D Fortune; 2001 Jul; 144(2):74-6, 78, 80. PubMed ID: 11471357 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]